179 related articles for article (PubMed ID: 34024165)
1. Evaluation of the Safety and Efficacy of a Novel Thrombin Containing Combination Hemostatic Powder Using a Historical Control.
Bruckner BA; Spotnitz WD; Suarez E; Loebe M; Ngo U; Gillen DL; Manson RJ
Clin Appl Thromb Hemost; 2021; 27():10760296211017238. PubMed ID: 34024165
[TBL] [Abstract][Full Text] [Related]
2. Microporous polysaccharide hemosphere absorbable hemostat use in cardiothoracic surgical procedures.
Bruckner BA; Blau LN; Rodriguez L; Suarez EE; Ngo UQ; Reardon MJ; Loebe M
J Cardiothorac Surg; 2014 Aug; 9():134. PubMed ID: 25085116
[TBL] [Abstract][Full Text] [Related]
3. Prospective, multicenter, randomized, controlled trial evaluating the performance of a novel combination powder vs hemostatic matrix in cardiothoracic operations.
Dang NC; Ardehali A; Bruckner BA; Parrino PE; Gillen DL; Hoffman RW; Spotnitz R; Cavoores S; Shorn IJ; Manson RJ; Spotnitz WD
J Card Surg; 2020 Feb; 35(2):313-319. PubMed ID: 31763732
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Hemostatic Efficacy of Two Powdered Topical Absorbable Hemostats Using a Porcine Liver Abrasion Model of Mild to Moderate Bleeding.
MacDonald MH; Tasse L; Wang D; Zhang G; De Leon H; Kocharian R
J Invest Surg; 2021 Nov; 34(11):1198-1206. PubMed ID: 32928005
[TBL] [Abstract][Full Text] [Related]
5. A Prospective Analysis of the Effects of a Powder-Type Hemostatic Agent on the Short-Term Outcomes after Liver Resection.
Kang M; Cho JY; Han HS; Yoon YS; Lee HW; Lee B; Park Y; Kim J
Medicina (Kaunas); 2024 Feb; 60(2):. PubMed ID: 38399565
[No Abstract] [Full Text] [Related]
6. Cost-consequence analysis of a hemostatic matrix alone or in combination for spine surgery patients.
Ramirez MG; Niu X; Epstein J; Yang D
J Med Econ; 2018 Oct; 21(10):1041-1046. PubMed ID: 30112922
[TBL] [Abstract][Full Text] [Related]
7. Application techniques of a novel hemostat in cardiac operations: HEMOBLAST.
Bruckner BA; Ngo U; Ramchandani M; Suarez E; Awad S; Reardon M
J Card Surg; 2019 Sep; 34(9):849-853. PubMed ID: 31348840
[TBL] [Abstract][Full Text] [Related]
8. Various local hemostatic agents with different modes of action; an in vivo comparative randomized vascular surgical experimental study.
Björses K; Holst J
Eur J Vasc Endovasc Surg; 2007 Mar; 33(3):363-70. PubMed ID: 17137801
[TBL] [Abstract][Full Text] [Related]
9. The combination of platelet-enriched autologous plasma with bovine collagen and thrombin decreases the need for multiple blood transfusions in trauma patients with retroperitoneal bleeding.
Bochicchio G; Dunne J; Bochicchio K; Scalea T
J Trauma; 2004 Jan; 56(1):76-9. PubMed ID: 14749569
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the safety and efficacy of a new hemostatic powder using a quantitative surface bleeding severity scale.
Ardehali A; Spotnitz WD; Hoffman RW; Olson SA; Bochicchio GV; Hermann MC; Lakshman S; Dang NC; Centis V; Gillen DL; Schorn IJ; Spotnitz RH;
J Card Surg; 2019 Jan; 34(1):50-62. PubMed ID: 30629770
[TBL] [Abstract][Full Text] [Related]
11. Gelatin-thrombin hemostatic matrix in neurosurgical procedures: hemostatic effectiveness and economic value of clinical and surgical procedure-related benefits.
Esposito F; Cappabianca P; Angileri FF; Cavallo LM; Priola SM; Crimi S; Solari D; Germanò AF; Tomasello F
J Neurosurg Sci; 2020 Apr; 64(2):158-164. PubMed ID: 27456032
[TBL] [Abstract][Full Text] [Related]
12. A comparison of recombinant thrombin to bovine thrombin as a hemostatic ancillary in patients undergoing peripheral arterial bypass and arteriovenous graft procedures.
Weaver FA; Lew W; Granke K; Yonehiro L; Delange B; Alexander WA;
J Vasc Surg; 2008 Jun; 47(6):1266-73. PubMed ID: 18440754
[TBL] [Abstract][Full Text] [Related]
13. Hemostatic efficacy of EVARREST™, Fibrin Sealant Patch vs. TachoSil® in a heparinized swine spleen incision model.
Matonick JP; Hammond J
J Invest Surg; 2014 Dec; 27(6):360-5. PubMed ID: 25361019
[TBL] [Abstract][Full Text] [Related]
14. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.
Mathiasen RA; Cruz RM
Otolaryngol Head Neck Surg; 2004 Nov; 131(5):601-5. PubMed ID: 15523433
[TBL] [Abstract][Full Text] [Related]
15. The use fibrinogen/thrombin-coated equine collagen patch in children requiring reoperations for congenital heart disease. A single center clinical experience.
Vida VL; De Franceschi M; Barzon E; Padalino MA; Scattolin F; Stellin G
J Cardiovasc Surg (Torino); 2014 Jun; 55(3):401-6. PubMed ID: 24755705
[TBL] [Abstract][Full Text] [Related]
16. A Comparative Study of the Resorption and Immune Response for Two Starch-Based Hemostat Powders.
Capella-Monsonís H; Shridhar A; Chirravuri B; Figucia M; Learn G; Greenawalt K; Badylak SF
J Surg Res; 2023 Feb; 282():210-224. PubMed ID: 36327703
[TBL] [Abstract][Full Text] [Related]
17. Managing port-site bleeding during less invasive coronary artery bypass grafting.
Kiani S; Brecht ML; Lovinger K; Poston RS
Heart Surg Forum; 2012 Oct; 15(5):E272-6. PubMed ID: 23092664
[TBL] [Abstract][Full Text] [Related]
18. An Efficacy Comparison of Two Hemostatic Agents in a Porcine Liver Bleeding Model: Gelatin/Thrombin Flowable Matrix versus Collagen/Thrombin Powder.
Slezak P; Keibl C; Redl H; Labahn D; Gulle H
J Invest Surg; 2020 Oct; 33(9):828-838. PubMed ID: 30907197
[No Abstract] [Full Text] [Related]
19. Experimental Evaluation of Tranexamic Acid-Loaded Porous Starch as a Hemostatic Powder.
Xi C; Zhu L; Zhuang Y; Wang S; Sun G; Liu Y; Wang D
Clin Appl Thromb Hemost; 2018 Mar; 24(2):279-286. PubMed ID: 28731369
[TBL] [Abstract][Full Text] [Related]
20. A review of three stand-alone topical thrombins for surgical hemostasis.
Cheng CM; Meyer-Massetti C; Kayser SR
Clin Ther; 2009 Jan; 31(1):32-41. PubMed ID: 19243705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
